Abstract: Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.

Abstract: An anti-IL-23 antibody, including isolated nucleic acids that encode at least one anti-IL-23 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Abstract: Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.

Abstract: The present invention provides antibodies immunospecific for human CD147 capable of blocking bioactivity of CD147 associated with malignant disease such as the stimulation of MMPs from fibroblast cells by tumor cells, the release of VEGF, and the promotion of angiogenesis. The antibodies of the present invention of are useful in treating malignant disease and those diseases in which CD147 activity is plays a pathogenic role, such as diseases of the eye, lung, and cardiovascular system.

Abstract: An anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Abstract: Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.

Abstract: The computerized method and apparatus for mobile device interactivity includes hosting a network application on a server. The method and apparatus further includes receiving, at the network application on the server, an event message from a mobile application executing on a mobile device, the mobile application having executable code embedded therein for communicating with the network information for presenting a user interface for the network application on the mobile device, the event message reporting an action taken via the user interface. The method and apparatus further including executing application logic within the network application to generate data values based on the action reported in the event message and mobile device information and sending to the mobile device an update message with at least some of the generated data values and instructions for use by the executable code to present the data values within the user interface at the mobile device.

Abstract: The present invention provides antibodies immunospecific for human CD147 capable of blocking bioactivity of CD147 associated with malignant disease such as the stimulation of MMPs from fibroblast cells by tumor cells, the release of VEGF, and the promotion of angiogenesis. The antibodies of the present invention of are useful in treating malignant disease and those diseases in which CD147 activity is plays a pathogenic role, such as diseases of the eye, lung, and cardiovascular system.

Abstract: The computerized method and apparatus for mobile device interactivity includes hosting a network application on a server. The method and apparatus further includes receiving, at the network application on the server, an event message from a mobile application executing on a mobile device, the mobile application having executable code embedded therein for communicating with the network information for presenting a user interface for the network application on the mobile device, the event message reporting an action taken via the user interface. The method and apparatus further including executing application logic within the network application to generate data values based on the action reported in the event message and mobile device information and sending to the mobile device an update message with at least some of the generated data values and instructions for use by the executable code to present the data values within the user interface at the mobile device.

Abstract: An anti-IL-23 antibody, including isolated nucleic acids that encode at least one anti-IL-23 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Abstract: Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.

Abstract: Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.

Abstract: Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.

Abstract: Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.

Abstract: Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.

Abstract: An apparatus and method are disclosed and pertain to a lid for use with a container having a rim and an opening where volatile esters from an aromatic compound are dispersing into the environment and for enhancing the identification of the volatile esters. The lid is comprised of a generally planar laterally stabilized gas restrictive material for decreasing the dispersion rate of the volatile esters, resulting in increased concentration of the volatile esters within the container and enhancing the identification of the volatile esters emitted from the aromatic compound. The lid includes a surface for coupling to the rim in a manner that laterally stabilizes the lid so that it remains sufficiently fixed to the rim during agitation of the container. The surface also permits the lid to be removed from the rim.

Abstract: Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.

Abstract: A method and system are disclosed for delivering interactive links for presenting applications and second information at a client computer from remote sources in a network-configured computer processing system. In one embodiment, the method includes retrieving over a first communication connection, in response to a request of a client computer, informational content having computer program code embedded therein, and executing the embedded computer program code for establishing a second communication connection to an application server. The method further includes retrieving over the second communication connection first information including presentational information for presenting the application and the second information.

Abstract: The computerized method and apparatus for mobile device interactivity includes hosting a network application on a server. The method and apparatus further includes receiving, at the application on the server, an event message from a mobile application executing on a mobile device, the application having executable code embedded therein for communicating with the network information for presenting a user interface for the network application on the mobile device, the event message reporting an action taken via the user interface. The method and apparatus further including executing application logic within the network application to generate data values based on the action reported in the event message and mobile device information and sending to the mobile device an update message with at least some of the generated data values and instructions for use by the executable code to present the data values within the user interface at the mobile device.

Abstract: An anti-IL-23 antibody, including isolated nucleic acids that encode at least one anti-IL-23 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.